Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Siyue Zheng"'
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background Since the publication of MA-20 and EORTC-22922 trials, chest wall (CW)/ whole breast (WB) irradiation + comprehensive regional nodal irradiation (RNI) with internal mammary node irradiation (IMNI) has been the standard adjuvant tr
Externí odkaz:
https://doaj.org/article/d1d5836c4ef8419daa238a558d76a340
Publikováno v:
Cardiovascular Innovations and Applications, Vol 9, Iss 1, p 986 (2024)
Background: A large gap exists between the needs of patients with end-stage heart failure and the number of gold-standard heart transplants. Over the past 30 years, a revolutionary treatment strategy using ventricular assist devices (VADs) has rapidl
Externí odkaz:
https://doaj.org/article/af28556c20d345889882bc6abdc3ac42
Autor:
Min Li, Fei Xu, Jian Li, Min Chen, Mei Chen, Cheng Xu, Yuan Yao, Rong Cai, Qing Lin, Xiao Lin, Yimin Han, Feifei Xu, Jinrong Xie, Yutian Zhao, Gang Cai, Qiwei Zhu, Shubei Wang, Xiaolu Tang, Chuying Chen, Siyue Zheng, Xiaofang Qian, Chunhong Shen, Haoping Xu, Dan Ou, Kun Wei Shen, Wei-Xiang Qi, Lu Cao, Xiaobo Huang, Jiayi Chen
Publikováno v:
BMJ Open, Vol 12, Iss 9 (2022)
Introduction Short course regimen has become the major trend in the field of adjuvant radiotherapy for patients with breast cancer. Hypofractionated radiotherapy (HF-RT) regimen of 40–42.5 Gy in 15–16 fractions has been established as a preferred
Externí odkaz:
https://doaj.org/article/f8c3414812cc4aa491dac125758d6992
Publikováno v:
Thoracic Cancer, Vol 12, Iss 8, Pp 1180-1186 (2021)
Abstract Background This was a single institute, phase I/II study of salvage chemoradiotherapy (CRT) with simultaneous integrated boost in patients with mediastinal lymph node (LN) recurrence after esophagectomy. Methods Patients who presented with a
Externí odkaz:
https://doaj.org/article/7de68f21ef804816852e9607f04d58fb
Autor:
Siyue Zheng, Chu-Ying Chen, Wei-Xiang Qi, Gang Cai, Cheng Xu, Rong Cai, Xiao-Fang Qian, Kun-Wei Shen, Lu Cao, Jia-Yi Chen
Publikováno v:
The Breast. 68:142-148
Purpose To explore the risk factors for breast cancer-related lymphedema (BCRL) and upper extremity dysfunction (UED) in patients with early breast cancer after modern comprehensive treatment and to compare the safety of various treatment strategies.
Publikováno v:
International Journal of Molecular Sciences
Volume 24
Issue 5
Pages: 4593
Volume 24
Issue 5
Pages: 4593
M2-like polarized tumor-associated macrophages (TAMs) are the major component of infiltrating immune cells in hepatocellular carcinoma (HCC), which have been proved to exhibit significant immunosuppressive and pro-tumoral effects. However, the underl
Publikováno v:
Thoracic Cancer, Vol 12, Iss 8, Pp 1180-1186 (2021)
Thoracic Cancer
Thoracic Cancer
Background This was a single institute, phase I/II study of salvage chemoradiotherapy (CRT) with simultaneous integrated boost in patients with mediastinal lymph node (LN) recurrence after esophagectomy. Methods Patients who presented with a clinical
Autor:
Siyue Zheng
Publikováno v:
2022 3rd International Conference on Computer Vision, Image and Deep Learning & International Conference on Computer Engineering and Applications (CVIDL & ICCEA).
Autor:
Siyue Zheng, Jijun KANG
Publikováno v:
SSRN Electronic Journal.
Autor:
Jinrong Xie, Feifei Xu, Yutian Zhao, Gang Cai, Xiao Lin, Qiwei Zhu, Qing Lin, Yuan Yao, Cheng Xu, Rong Cai, Shubei Wang, Xiaolu Tang, Chuying Chen, Siyue Zheng, Mei Chen, Min Chen, Xiaofang Qian, Chunhong Shen, Jian Li, Haoping Xu, Fei Xu, Yimin Han, Min Li, Dan Ou, Kun Wei Shen, Wei-Xiang Qi, Lu Cao, Xiaobo Huang, Jiayi Chen
Publikováno v:
BMJ Open. 12:e062034
IntroductionShort course regimen has become the major trend in the field of adjuvant radiotherapy for patients with breast cancer. Hypofractionated radiotherapy (HF-RT) regimen of 40–42.5 Gy in 15–16 fractions has been established as a preferred